EDP Sciences logo
Rechercher
Menu
Tous les numéros Volume 23 / Numéro 2 (2011) Ann Toxicol Anal, 23 2 (2011) 71-82 Références
Open Access
Numéro
Ann Toxicol Anal
Volume 23, Numéro 2, 2011
Page(s) 71 - 82
DOI https://doi.org/10.1051/ata/2011113
Publié en ligne 7 juillet 2011
  1. Eddleston M, Eyer P, Worek F, Mohamed F, Senarathna L, von Meyer L, Juszczak E, Hittarage A, Azhar S, Dissanayake W, Sheriff MH, Szinicz L, Dawson AH, Buckley NA. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet. 2005; 366: 1452-1459. [CrossRef] [PubMed] [Google Scholar]
  2. Satoh T. Global Epidemiology of Organophosphate and Carbamate Poisosings. In: Toxicology of Organophosphate and Carbamate Compounds. Elsevier, 2006: p. 89-100. [Google Scholar]
  3. Namba T. Cholinesterase inhibition by organophosphorus compounds and its clinical effects. Bull World Health Organ. 1971; 44: 289-307. [PubMed] [Google Scholar]
  4. Goswamy R, Chaudhuri A, Mahashur AA. Study of respiratory failure in organophosphate and carbamate poisoning. Heart Lung. 1994; 23: 466-472. [PubMed] [Google Scholar]
  5. Segura P, Chavez J, Montano LM, Vargas MH, Delaunois A, Carbajal V, Gustin P. Identification of mechanisms involved in the acute airway toxicity induced by parathion. Naunyn Schmiedebergs Arch Pharmacol. 1999; 360: 699-710. [CrossRef] [PubMed] [Google Scholar]
  6. Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute organophosphorus pesticide poisoning. Lancet. 2008; 371: 597-607. [CrossRef] [PubMed] [Google Scholar]
  7. De Candole C, Douglas W, Evans C, Holmes E, Spencer K, Torrance R, Wilson K. The failure of respiration in death by anticholinesterase poisoning. Br J Pharmacol. 1953; 8: 466-475. [Google Scholar]
  8. Tsao TC, Juang YC, Lan RS, Shieh WB, Lee CH. Respiratory failure of acute organophosphate and carbamate poisoning. Chest. 1990; 98: 631-636. [CrossRef] [PubMed] [Google Scholar]
  9. Betrosian A, Balla M, Kafiri G, Kofinas G, Makri R, Kakouri A. Multiple systems organ failure from organophosphate poisoning. J Toxicol Clin Toxicol. 1995; 33: 257-260. [CrossRef] [PubMed] [Google Scholar]
  10. Thompson JW, Stocks RM. Brief bilateral vocal cord paralysis after insecticide poisoning. A new variant of toxicity syndrome. Arch Otolaryngol Head Neck Surg. 1997; 123: 93-96. [Google Scholar]
  11. Lund C, Monteagudo FS. Therapeutic Protocol No. 1. Early management of organophosphate poisoning. S Afr Med J. 1986; 69: 6. [PubMed] [Google Scholar]
  12. Gies JP, Bertrand C, Vanderheyden P, Waeldele F, Dumont P, Pauli G, Landry Y. Characterization of muscarinic receptors in human, guinea pig and rat lung. J Pharmacol Exp Ther. 1989; 250: 309-315. [PubMed] [Google Scholar]
  13. Villa AF, Houze P, Monier C, Risede P, Sarhan H, Borron SW, Megarbane B, Garnier R, Baud FJ. Toxic doses of paraoxon alter the respiratory pattern without causing respiratory failure in rats. Toxicology. 2007; 232: 37-49. [CrossRef] [PubMed] [Google Scholar]
  14. Houze P, Pronzola L, Kayouka M, Villa A, Debray M, Baud FJ. Ventilatory effects of low-dose paraoxon result from central muscarinic effects. Toxicol Appl Pharmacol. 2008; 233: 186-192. [CrossRef] [PubMed] [Google Scholar]
  15. Namba T. Diagnosis and treatment of organophosphate insecticide poisoning. Med Times. 1972; 100: 100-101. [PubMed] [Google Scholar]
  16. Brahmi N, Mokline A, Kouraichi N, Ghorbel H, Blel Y, Thabet H, Hedhili A, Amamou M. Prognostic value of human erythrocyte acetyl cholinesterase in acute organophosphate poisoning. Am J Emerg Med. 2006; 24: 822-827. [CrossRef] [PubMed] [Google Scholar]
  17. Yurumez Y, Durukan P, Yavuz Y, Ikizceli I, Avsarogullari L, Ozkan S, Akdur O, Ozdemir C. Acute organophosphate poisoning in university hospital emergency room patients. Intern Med. 2007; 46: 965-969. [CrossRef] [PubMed] [Google Scholar]
  18. Sungur M, Guven M. Intensive care management of organophosphate insecticide poisoning. Crit Care. 2001; 5: 211-215. [CrossRef] [PubMed] [Google Scholar]
  19. Saadeh AM, al-Ali MK, Farsakh NA, Ghani MA. Clinical and sociodemographic features of acute carbamate and organophosphate poisoning: a study of 70 adult patients in north Jordan. J Toxicol Clin Toxicol. 1996; 34: 45-51. [CrossRef] [PubMed] [Google Scholar]
  20. Eddleston M, Gunnell D, Karunaratne A, de Silva D, Sheriff MH, Buckley NA. Epidemiology of intentional self-poisoning in rural Sri Lanka. Br J Psychiatry. 2005; 187: 583-584. [CrossRef] [PubMed] [Google Scholar]
  21. Reuber MD. Carcinogenicity of dichlorvos. Clin Toxicol. 1981; 18: 47-84. [CrossRef] [PubMed] [Google Scholar]
  22. DiGiacomo RF, Brodie SJ, Giddens Jr. WE, Van Hoosier GL, Jr. Dichlorvos toxicity in the white-footed mouse (Peromyscus leucopus). Lab Anim Sci. 1987; 37: 471-473. [PubMed] [Google Scholar]
  23. International Programme on Chemical Safety. The WHO Recommended Classification of Pesticides by Hazard and Guidelines to Classification. World health Organization, Geneva, 2002. [Google Scholar]
  24. Bruce RD. An up-and-down procedure for acute toxicity testing. Fundam Appl Toxicol. 1985; 5: 151-157. [CrossRef] [PubMed] [Google Scholar]
  25. Bruce RD. A confirmatory study of the up-and-down method for acute oral toxicity testing. Fundam Appl Toxicol. 1987; 8: 97-100. [CrossRef] [PubMed] [Google Scholar]
  26. Dixon WJ. Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev. 1991; 15: 47-50. [CrossRef] [PubMed] [Google Scholar]
  27. Bartlett D. Jr, Tenney SM. Control of breathing in experimental anemia. Respir. Physiol. 1970; 10: 384-395. [CrossRef] [PubMed] [Google Scholar]
  28. Boudinot E, Morin-Surun M, Foutz AS, Fournie-Zaluski M, Roques BP, Denavit-Saubie M. Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration. Pain. 2001; 90: 7-13. [CrossRef] [PubMed] [Google Scholar]
  29. Bardin PG, van Eeden SF, Joubert JR. Intensive care management of acute organophosphate poisoning. A 7-year experience in the western Cape. S Afr Med J. 1987; 72: 593-597. [Google Scholar]
  30. Groszek B, Pach J, Klys M. Intermediate syndrome in acute fenitrothion poisoning. Przegl Lek. 1995; 52: 271-274. [PubMed] [Google Scholar]
  31. Eddleston M, Buckley N, Eyer P, Dawson A. Management of acute organophosphorus pesticide poisoning. Lancet. 2008; 371: 597-607. [CrossRef] [PubMed] [Google Scholar]
  32. Pawar KS, Bhoite RR, Pillay CP, Chavan SC, Malshikare DS, Garad SG. Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial. Lancet. 2006; 368: 2136-2141. [CrossRef] [PubMed] [Google Scholar]
  33. Gajewski D, Katkiewicz M. Activity of certain enzymes and histomorphological changes in subacute intoxication of rats with selected organophosphates. Acta Physiol Pol. 1981; 32: 507-520. [PubMed] [Google Scholar]
  34. Takahashi H, Kojima T, Ikeda T, Tsuda S, Shirasu Y. Differences in the mode of lethality produced through intravenous and oral administration of organophosphorus insecticides in rats. Fundam Appl Toxicol. 1991; 16: 459-468. [CrossRef] [PubMed] [Google Scholar]
  35. Johnson Rowsey P, Gordon CJ. Tolerance to the hypothermic and hyperthermic effects of chlorpyrifos. Toxicology. 1997; 121: 215-221. [CrossRef] [PubMed] [Google Scholar]
  36. Foutz AS, Boudinot E, Denavit-Saubie M. Central respiratory depression induced by acetylcholinesterase inhibition: involvement of anaesthesia. Eur J Pharmacol. 1987; 142: 207-213. [CrossRef] [PubMed] [Google Scholar]
  37. RTECSr. Registry of Toxic Effects of Chemical Substances. In: Canada, 2004-3 edition Hamilton, Canadian Centre for Occupational Health and Safety (CCOHS), MDL Information Systems, Inc., 2005. [Google Scholar]
  38. Aas P, Veiteberg TA, Fonnum F. Acute and sub-acute inhalation of an organophosphate induce alteration of cholinergic muscarinic receptors. Biochem Pharmacol. 1987; 36: 1261-1266. [CrossRef] [PubMed] [Google Scholar]
  39. Johnson DD, Wilcox WC. Studies on the mechanism of the protective and antidotal actions of diazepam in organophosphate poisoning. Eur J Pharmacol. 1975; 34: 127-132. [CrossRef] [PubMed] [Google Scholar]
  40. Nambiar MP, Gordon RK, Rezk PE, Katos AM, Wajda NA, Moran TS, Steele KE, Doctor BP, Sciuto AM. Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX. Toxicol Appl Pharmacol. 2007; 219: 142-150. [CrossRef] [PubMed] [Google Scholar]
  41. Worek F, Kleine A, Falke K, Szinicz L. Arrhythmias in organophosphate poisoning: effect of atropine and bispyridinium oximes. Arch Int Pharmacodyn Ther. 1995; 329: 418-435. [PubMed] [Google Scholar]
  42. Eddleston M, Singh S, Buckley N. Organophosphorus poisoning (acute). Clin Evid. 2005: 1744-1755. [Google Scholar]
  43. Chavez J, Segura P, Vargas MH, Arreola JL, Flores-Soto E, Montano LM. Paradoxical effect of salbutamol in a model of acute organophosphates intoxication in guinea pigs: role of substance P release. Am J Physiol Lung Cell Mol Physiol. 2007; 292: L915-923. [CrossRef] [PubMed] [Google Scholar]
  44. Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, Brodkin J, Grinberg A, Sheng H, Wess J. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A. 1999; 96: 1692-1697. [CrossRef] [PubMed] [Google Scholar]
  45. Dickson EW, Bird SB, Gaspari RJ, Boyer EW, Ferris CF. Diazepam inhibits organophosphate-induced central respiratory depression. Acad Emerg Med. 2003; 10: 1303-1306. [CrossRef] [PubMed] [Google Scholar]
  46. Kokshavera N, Prodanchuk N, Zhminko P, Krivenchuk. Cholinesterase blockers as potential agents for chemical terrorism and contemporary approaches to therapy of acute poisonings induced by anti-cholinesterase neuroparalytic substances. In Monov A, Dishovsky C editors. Medical aspects of chemical and biological terrorism. Chemical Terrorism and Traumatism. Sofia: Publishing house of the Union of Scientists in Bulgaria, 2005, 153-182. [Google Scholar]
  47. Witter A, Slangen JL, Terpstra GK. Distribution of 3H-methylatropine in rat brain. Neuropharmacology. 1973; 12: 835-841. [CrossRef] [PubMed] [Google Scholar]
  48. Smith RD, Grzelak ME, Coffin VL. Methylatropine blocks the central effects of cholinergic antagonists. Behav Pharmacol. 1994; 5: 167-175. [PubMed] [Google Scholar]
  49. Brezenoff HE, Xiao YF, Vargas H. A comparison of the central and peripheral antimuscarinic effects of atropine and methylatropine injected systemically and into the cerebral ventricles. Life Sci. 1988; 42: 905-911. [CrossRef] [PubMed] [Google Scholar]